TY - JOUR
T1 - Therapeutic Effects of Curcumol in Several Diseases; An Overview
AU - Hashem, Sheema
AU - Nisar, Sabah
AU - Sageena, Geetanjali
AU - Macha, Muzafar A.
AU - Yadav, Santosh K.
AU - Krishnankutty, Roopesh
AU - Uddin, Shahab
AU - Haris, Mohammad
AU - Bhat, Ajaz A.
N1 - Funding Information:
This study was supported by a grant from the Sidra Medical and Research Center (5011041002) to Ajaz A. Bhat. This study was funded by Sidra Medicine, Doha, Qatar. The authors thank Dr. Vineeta Tanwar (Research Scientist, Ohio State University, Ohio, Columbus, USA) for help in English editing and valuable suggestions to improve the quality of the manuscript.
Publisher Copyright:
© 2020 Taylor & Francis Group, LLC.
PY - 2021
Y1 - 2021
N2 - Curcumae Rhizoma, also known as Ezhu is a traditional Chinese medicine that has been used for many centuries against several diseases. The rhizome of the plant is composed of curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin), and essential volatile oils including curcumol, curdione, and germacrone. While curcuminoids have been extensively studied for their antimicrobial, antioxidant, anti-inflammatory and anticancer properties, the therapeutic efficacy of curcumol is still emerging. Recent studies have shown anticancer properties of curcumol against multiple solid tumors such as breast, colorectal, head and neck, and lung adenocarcinomas. The underlying anti-tumor mechanisms revealed inhibition of several signaling pathways (NF-κB, MAPK, PI-3K/AKT, and GSK-3β) associated with cell proliferation, survival, anti-apoptosis, invasion and metastasis. Besides curcumol, extracts from the Curcumae Rhizoma roots possess many other terpenoids such as β-elemene, δ-elemene, germacrone, furanodiene and furanodienone with known anticancer properties. In this review, we comprehensively focused on the composition of Curcumae Rhizoma essential oils, their structure, isolation and therapeutic uses of curcumol to aid in the improvement and development of novel drugs with minimal cytotoxicity, enhanced efficacy, and less cost.
AB - Curcumae Rhizoma, also known as Ezhu is a traditional Chinese medicine that has been used for many centuries against several diseases. The rhizome of the plant is composed of curcuminoids (curcumin, demethoxycurcumin, and bisdemethoxycurcumin), and essential volatile oils including curcumol, curdione, and germacrone. While curcuminoids have been extensively studied for their antimicrobial, antioxidant, anti-inflammatory and anticancer properties, the therapeutic efficacy of curcumol is still emerging. Recent studies have shown anticancer properties of curcumol against multiple solid tumors such as breast, colorectal, head and neck, and lung adenocarcinomas. The underlying anti-tumor mechanisms revealed inhibition of several signaling pathways (NF-κB, MAPK, PI-3K/AKT, and GSK-3β) associated with cell proliferation, survival, anti-apoptosis, invasion and metastasis. Besides curcumol, extracts from the Curcumae Rhizoma roots possess many other terpenoids such as β-elemene, δ-elemene, germacrone, furanodiene and furanodienone with known anticancer properties. In this review, we comprehensively focused on the composition of Curcumae Rhizoma essential oils, their structure, isolation and therapeutic uses of curcumol to aid in the improvement and development of novel drugs with minimal cytotoxicity, enhanced efficacy, and less cost.
KW - Antioxidant
KW - apoptosis
KW - cancer prevention
KW - dietary intervention
KW - oxidative stress
KW - transcription factors
UR - http://www.scopus.com/inward/record.url?scp=85083574192&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85083574192&partnerID=8YFLogxK
U2 - 10.1080/01635581.2020.1749676
DO - 10.1080/01635581.2020.1749676
M3 - Review article
C2 - 32285707
AN - SCOPUS:85083574192
SN - 0163-5581
VL - 73
SP - 181
EP - 195
JO - Nutrition and Cancer
JF - Nutrition and Cancer
IS - 2
ER -